NYSE:NHI - National Health Investors Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $70.25
  • Forecasted Upside: 17.10 %
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$59.99
▼ -0.51 (-0.84%)

This chart shows the closing price for NHI by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New National Health Investors Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NHI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NHI

Analyst Price Target is $70.25
▲ +17.10% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for National Health Investors in the last 3 months. The average price target is $70.25, with a high forecast of $77.00 and a low forecast of $64.00. The average price target represents a 17.10% upside from the last price of $59.99.

This chart shows the closing price for NHI for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 4 investment analysts is to buy stock in National Health Investors. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 1 sell ratings
7/28/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 6 hold ratings
  • 1 sell ratings
10/26/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 6 hold ratings
  • 1 sell ratings
1/24/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 6 hold ratings
  • 1 sell ratings
4/24/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 1 sell ratings
7/23/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 1 sell ratings
10/21/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 1 sell ratings
12/20/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
1/19/2022

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/7/2022BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$68.00High
11/9/2021Capital One FinancialUpgradeEqual Weight ➝ OverweightHigh
9/23/2021Truist FinancialLower Price TargetHold$71.00 ➝ $64.00Low
7/23/2021Wells Fargo & CompanyLower Price TargetEqual Weight$74.00 ➝ $72.00Low
6/18/2021BMO Capital MarketsUpgradeUnderperform ➝ Market Perform$71.00High
4/5/2021Wells Fargo & CompanyBoost Price TargetHold ➝ Equal Weight$66.00 ➝ $74.00Low
3/30/2021Capital One FinancialDowngradeOverweight ➝ Equal Weight$77.00Low
3/23/2021Truist FinancialBoost Price Target$69.00 ➝ $74.00Low
1/13/2021MizuhoDowngradeNeutral ➝ Underperform$56.00 ➝ $55.00Medium
1/7/2021BMO Capital MarketsDowngradeMarket Perform ➝ Underperform$68.00Low
12/14/2020KeyCorpUpgradeUnderweight ➝ Sector WeightMedium
12/2/2020Berenberg BankDowngradeBuy ➝ HoldLow
9/1/2020Stifel NicolausReiterated RatingHold$63.00High
6/24/2020SunTrust BanksBoost Price TargetHold$61.00 ➝ $64.00Low
6/17/2020Wells Fargo & CompanyBoost Price TargetEqual Weight$54.00 ➝ $66.00High
6/8/2020JMP SecuritiesInitiated CoverageMarket PerformHigh
5/22/2020MizuhoDowngradeBuy ➝ Neutral$60.00 ➝ $55.00Medium
5/14/2020KeyCorpLower Price TargetUnderweight$43.00 ➝ $40.00High
4/23/2020SunTrust BanksLower Price TargetHold$77.00 ➝ $61.00Low
4/21/2020KeyCorpLower Price TargetUnderweight$65.00 ➝ $43.00Medium
3/26/2020Wells Fargo & CompanyLower Price TargetEqual Weight$82.00 ➝ $51.00High
2/5/2020Berenberg BankInitiated CoverageBuy$94.00Medium
1/7/2020BMO Capital MarketsUpgradeUnderperform ➝ Market Perform$74.00 ➝ $82.00Low
12/20/2019MizuhoReiterated RatingBuy$95.00High
2/20/2019SunTrust BanksBoost Price TargetHold ➝ Neutral$85.00High
2/20/2019BMO Capital MarketsDowngradeMarket Perform ➝ Underperform$78.00Medium
12/20/2018KeyCorpSet Price TargetSell$65.00High
11/8/2018Cantor FitzgeraldReiterated RatingHold$80.00Low
8/28/2018Wells Fargo & CompanyReiterated RatingHoldLow
8/8/2018Cantor FitzgeraldBoost Price TargetNeutral ➝ Neutral$75.00 ➝ $80.00Low
8/8/2018SunTrust BanksReiterated RatingHold$79.00Medium
8/7/2018Stifel NicolausSet Price TargetBuy$83.00Medium
5/31/2018Wells Fargo & CompanySet Price TargetMarket Perform ➝ Market Perform$68.00 ➝ $75.00Low
5/16/2018Cantor FitzgeraldReiterated RatingNeutralMedium
5/11/2018Capital One FinancialUpgradeEqual Weight ➝ OverweightLow
5/8/2018Cantor FitzgeraldReiterated RatingHold$75.00Medium
4/17/2018KeyCorpLower Price TargetUnderweight ➝ Sell$70.00 ➝ $60.00Low
3/26/2018BMO Capital MarketsSet Price TargetHold$70.00Low
2/26/2018MizuhoReiterated RatingHold$70.00High
2/17/2018Stifel NicolausSet Price TargetBuy$76.00Medium
2/17/2018SunTrust BanksSet Price TargetHold$70.00Medium
2/16/2018Hilliard LyonsUpgradeNeutral ➝ BuyLow
2/16/2018Cantor FitzgeraldReiterated RatingHold$85.00High
1/22/2018SunTrust BanksSet Price TargetHold$75.00Low
1/17/2018Cantor FitzgeraldReiterated RatingHold$85.00Low
1/12/2018StephensSet Price TargetBuy$79.00High
12/19/2017KeyCorpReiterated RatingSector Weight ➝ UnderweightMedium
11/24/2017KeyCorpReiterated RatingHoldN/A
10/23/2017Capital One FinancialInitiated CoverageEqual WeightN/A
10/18/2017BMO Capital MarketsReiterated RatingHold$80.00N/A
10/10/2017SunTrust BanksInitiated CoverageHold$80.00N/A
10/4/2017MizuhoReiterated RatingHold$82.00Low
10/4/2017Stifel NicolausReiterated RatingBuy$82.00Low
9/17/2017KeyCorpReiterated RatingHoldLow
6/28/2017MizuhoReiterated RatingNeutralLow
6/21/2017Stifel NicolausBoost Price TargetBuy$80.00 ➝ $82.00Low
5/22/2017Bank of AmericaDowngradeNeutral ➝ Underperform$76.00Low
2/21/2017Cantor FitzgeraldReiterated RatingNeutral$75.00N/A
(Data available from 1/19/2017 forward)

News Sentiment Rating

0.09 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/23/2021
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/23/2021
  • 0 very positive mentions
  • 6 positive mentions
  • 5 negative mentions
  • 0 very negative mentions
8/22/2021
  • 2 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/21/2021
  • 2 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
10/21/2021
  • 0 very positive mentions
  • 7 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
11/20/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/20/2021
  • 0 very positive mentions
  • 8 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
1/19/2022

Current Sentiment

  • 0 very positive mentions
  • 8 positive mentions
  • 2 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
National Health Investors logo
National Health Investors, Inc. is a real estate investment trust, which engages in the sale-leaseback, joint-venture, mortgage, and mezzanine financing of senior housing and medical investments. Its portfolio includes lease, mortgage and other note investments in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities, specialty hospitals, and medical office buildings. The company was founded by W. Andrew Adams in 1991 and is headquartered in Murfreesboro, TN.
Read More

Today's Range

Now: $59.99
Low: $59.64
High: $60.86

50 Day Range

MA: $56.69
Low: $50.96
High: $61.45

52 Week Range

Now: $59.99
Low: $50.88
High: $78.56

Volume

278,377 shs

Average Volume

297,515 shs

Market Capitalization

$2.75 billion

P/E Ratio

19.17

Dividend Yield

5.95%

Beta

0.95

Frequently Asked Questions

What sell-side analysts currently cover shares of National Health Investors?

The following sell-side analysts have issued stock ratings on National Health Investors in the last twelve months: BMO Capital Markets, Capital One Financial Co., TheStreet, Truist Financial Co., Wells Fargo & Company, and Zacks Investment Research.
View the latest analyst ratings for NHI.

What is the current price target for National Health Investors?

4 Wall Street analysts have set twelve-month price targets for National Health Investors in the last year. Their average twelve-month price target is $70.25, suggesting a possible upside of 17.0%. Capital One Financial Co. has the highest price target set, predicting NHI will reach $77.00 in the next twelve months. Truist Financial Co. has the lowest price target set, forecasting a price of $64.00 for National Health Investors in the next year.
View the latest price targets for NHI.

What is the current consensus analyst rating for National Health Investors?

National Health Investors currently has 2 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe NHI will outperform the market and that investors should add to their positions of National Health Investors.
View the latest ratings for NHI.

What other companies compete with National Health Investors?

How do I contact National Health Investors' investor relations team?

National Health Investors' physical mailing address is 222 ROBERT ROSE DRIVE, MURFREESBORO TN, 37129. The real estate investment trust's listed phone number is (615) 890-9100 and its investor relations email address is [email protected] The official website for National Health Investors is www.nhireit.com.